The science
Azelaic acid is one of the better-evidenced topical actives in dermatology, though nearly all of that evidence comes from prescription concentrations. In a randomised trial of 251 patients with papulopustular rosacea published in Archives of Dermatology in 2003, 15 percent azelaic acid gel outperformed 0.75 percent metronidazole gel on inflammatory lesion count and erythema over 15 weeks, and an earlier double-blind vehicle-controlled study in Acta Dermato-Venereologica (1999) found 20 percent azelaic acid cream cut inflammatory rosacea lesions by about 73 percent against 51 percent for vehicle over three months. The mechanism is unusually broad for a single molecule: it inhibits tyrosinase and is selectively toxic to overactive melanocytes, which is the basis of its use for post-inflammatory marks and melasma; it reduces the abnormal keratinisation that forms comedones; it inhibits Cutibacterium acnes; and it lowers reactive oxygen species and kallikrein-5 activity in rosacea skin. What the literature does not contain is a controlled trial of 10 percent in an aloe gel, so any claim for this serum is an extrapolation downward from the prescription data, reasonable in direction but unquantified in size. The formulation matters more than usual here. Azelaic acid's solubility in water is low, and prescription vehicles use propylene glycol and polyacrylate systems to keep it in solution and drive it into skin. This serum has none of those, so a portion of the declared 10 percent exists as dispersed crystals, which reduces the fraction available for absorption and explains the residue users describe; the effective delivered dose is therefore somewhat below the label figure, even if the label figure is accurate. Niacinamide at a plausible 2 to 4 percent, judging by its fourth-place position, has independent trial support for reducing facial redness and for slowing melanosome transfer, and pairing it with a tyrosinase inhibitor is a rational two-step attack on pigment. The liposomal vitamin complex contributes trace retinyl palmitate, tocopheryl acetate and sodium ascorbyl phosphate, all at levels that add antioxidant garnish rather than measurable effect. Sodium hyaluronate and glycerin provide the surface hydration that keeps a 10 percent acid comfortable. The honest scientific summary is a moderate-dose, moderately delivered azelaic acid with a useful niacinamide partner, likely to help mild redness and marks and unlikely to match the trial results of the prescription vehicles.
References 2 ShowHide
- A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial — Archives of Dermatology (2003)
- Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea — Acta Dermato-Venereologica (1999)